OUR CAPITALS

Stakeholder Engagements

OUR CAPITALS

Stakeholder Engagements

Suppliers

Metrics used to measure quality of relationships:
Supplier engagement survey (Top 20 suppliers), Key performance indicators are:

  • Cost of doing business
  • Customer satisfaction and feedback
  • Flexibility and ease of doing business
  • Quality of service
  • Partnership

Management’s assessment of current relationship: Fair | Desired Relationship: Trusted | Responsible: Corporate Services Executive

Stakeholder Needs, Interests and Expectations

  • Payments for goods and services rendered
  • Fair, ethical and transparent procurement processes/tenders, etc

Key Risks

  • Goods and services not delivered at the right time, right quality and as per specifications
  • Product quality failure and wastage
  • Delayed or no blood or blood products delivery to patients
  • System downtime
  • Increased costs
  • Poor contract management
  • Lack of B-BBEE
  • Vendors preferring not to do business with SANBS
  • Litigation

Opportunities

  • Formal engagement plan for critical vendors
  • Efficiencies and competencies
  • Improved supply chain management
  • Just-in-time inventory management
  • Digitalisation
  • Improved contract management
  • Encourage B-BBEE
  • Internal training on good procurement processes

SANBS Response

Ongoing Engagement
  • Critical vendor list
  • Procurement plan to address B-BBEE
  • Flexible procurement and strategic partnership
  • Contract management
  • New procurement framework and updated procurement procedures

Status of Current Engagements

  • New Procurement Policy implemented in FY21, which introduced flexible procurement and strategic partnerships, has resulted in improvements in stakeholder relationships (Positive feedback in supplier engagement survey)
  • New/updated procurement procedures to be implemented FY2024/25 will further increase efficiency.
  • Preferential procurement increased significantly during the year
  • B-BBEE scores increased significantly – Procurement achieved 53.67 out of 54 points and SANBS moved to Level 3 in early FY25

SA and International Blood Partners

Business partners: NBI, WCBS, ISBT, AfSBT, AABB & SASBT

Metrics used to measure quality of relationships: Blood safety meeting attendance and engagement, Meeting the contractual obligations of plasma supply, Working party membership, Research collaborations

Management’s assessment of current relationship: Good | Desired Relationship: Trusted | Responsible: Executive management, Senior management

Stakeholder Needs, Interests and Expectations

  • National supply management of all blood products (WCBS) and plasma for fractionation (NBI)
  • Collaboration in seamless national product and service delivery
  • Alignment of quality and safety
  • Ensuring product availability

Key Risks

  • Disparate approach to common challenges
  • Increased legal risk in the absence of collaboration
  • Reputation
  • Risk of unmet demand for plasma-derived medicinal products

Opportunities

  • Integrated South African blood services
  • Improved service delivery
  • Consistent decision making
  • Showcase the work of SANBS at conferences and in publications of these organisations
  • Improve SANBS reputation as a centre of excellence globally
  • Continuous quality improvement through participation in expert committees

SANBS Response

Regular Engagement
  • Service level agreements
  • Collaboration on common policies, procedures and standards
  • NHI response
  • Annual National Blood Safety Committee meetings
  • Sharing of blood and blood products when there are localised shortages
  • Research collaborations
  • Actively encourage participation of employees in many working parties, societies and organisations
  • SASBT and ISBT co-organised regional ISBT congress

Status of Current Engagements

  • Annual National Blood Safety Committee Meeting with representatives from SANBS, WCBS and NBI ensures an ongoing platform for addressing ongoing and acute risks in transfusion medicine
  • Quarterly Emerging Infectious Disease (EID) subcommittee meetings with SANBS, WCBS, NBI and NICD to assess the global landscape for transfusion transmissible emerging and re-emerging pathogens as well as an ongoing risk-based analysis to inform future decisions on mitigating bacterial contamination of platelets
  • Nomination and recently elected AfSBT President elect
  • SANBS had meetings with NBI, focusing on the demand for plasma- derived medicinal products
  • Extensive collaboration with WCBS ensuring a uniform approach to blood safety challenges, pathogen reduction, low collections and product offering
  • Collaboration with WCBS (as part of the South African Society for Blood Transfusion) and ISBT on the successful the Regional ISBT Congress to be held in November 2023 in Cape Town
  • Revision of the “Guidelines for the use of blood and blood products in South Africa”
  • Nomination and recently elected ISBT Regional director: Africa
  • Research collaboration with WCBS on Malaria testing